Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
Mark Merchant(Revolution Medicines (United States)), Melissa R. Junttila(Unknown)
Cited by 92
Related Papers
Disruption of IRE1α through its kinase domain attenuates multiple myeloma
|Proceedings of the National Academy of Sciences|2019|115